Figure 10. CSCs promotes tumor growth in vivo than in non-CSCs. A mouse model of Pancreatic cancer was established by subcutaneously inoculating CSCs and non-CSCs. (A) xenograft tumors of each group were shown; (B) Tumor volume was measured every week. (C) The mRNA level of miR-497/ NFkB1 /Ki67/ CD147/MMP-2 in tumors. **p < 0.01, compared to non-CSCs.